2401, 2022
Selenase – Kora Healthcare Appointed Selenase Marketing Authorisation Holder
SELENASE - KORA HEALTHCARE APPOINTED SELENASE MARKETING AUTHORISATION HOLDER Dublin, Ireland, 24 January 2022. Biosyn Arzneimittel GmbH and Kora Healthcare concluded an exclusive licensing agreement for the continued supply and commercialisation of selenase ® (sodium selenite pentahydrate) in the United Kingdom for the treatment of